Skip to main content
Kindstar Globalgene Technology, Inc. logo

Kindstar Globalgene Technology, Inc. — Investor Relations & Filings

Ticker · 9960 HKEX Human health and social work activities
Open in API
Filings indexed 599 across all filing types
Latest filing 2026-04-24 Proxy Solicitation & In…
Country HK Hong Kong
Listing HKEX 9960

About Kindstar Globalgene Technology, Inc.

http://www.kindstar.com.cn

Kindstar Globalgene Technology, Inc. is a leading independent provider of advanced specialty clinical testing services, specializing in esoteric testing. The company maintains the largest esoteric testing portfolio in its market, utilizing internationally-advanced laboratory facilities for clinical testing, scientific research, and applied R&D. Its comprehensive testing menu, featuring over 100 items, covers critical diagnostic areas including hematology, genetic diseases, gynecology, infectious diseases, neurology, and oncology. These services provide physicians and patients access to specialized diagnostics crucial for the diagnosis and treatment of major diseases.

Recent filings

Filing Released Lang Actions
PROXY FORM FOR THE ANNUAL GENERAL MEETING TO BE HELD ON FRIDAY, JUNE 5, 2026 (OR ANY ADJOURNMENT THEREOF)
Proxy Solicitation & Information Statement Classification · 1% confidence The document is a proxy form used by shareholders to appoint proxies and vote at the upcoming Annual General Meeting. It does not contain financial results or management discussion but is part of the materials sent to solicit shareholder votes at the AGM. This matches the definition of Proxy Solicitation & Information Statement (PSI).
2026-04-24 English
NOTICE OF ANNUAL GENERAL MEETING
Proxy Solicitation & Information Statement Classification · 1% confidence The document is a formal Notice of Annual General Meeting including the agenda, resolutions to be voted on, proxy appointment instructions, record dates, and voting procedures. It is a solicitation of shareholder votes and information statement for the AGM rather than the AGM presentation itself or the results. This matches the definition of Proxy Solicitation & Information Statement (PSI).
2026-04-24 English
PROPOSED RE-ELECTION OF DIRECTORS PROPOSED RE-APPOINTMENT OF AUDITOR PROPOSED GRANTING OF GENERAL MANDATES TO REPURCHASE SHARES AND TO ISSUE SHARES AND SELL TREASURY SHARES PROPOSED PAYMENT OF FINAL D
Regulatory Filings
2026-04-24 English
2025 Annual Report
Regulatory Filings
2026-04-24 English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 March 2026
Regulatory Filings Classification · 1% confidence The document is a mandatory monthly regulatory return (Form FF301) filed with the Hong Kong Exchange under Chapter 19B of the Listing Rules, detailing movements in share capital, issued and treasury shares, public float sufficiency and providing statutory confirmations. It is neither an earnings announcement, proxy statement, nor an annual/interim report, but a periodic listing‐rule compliance filing. This falls under the fallback category of general regulatory filings.
2026-04-08 English
(1) ANNUAL RESULTS ANNOUNCEMENT FOR THE YEAR ENDED DECEMBER 31, 2025; (2) FORMULATION OF GUIDELINES FOR FINAL DIVIDEND DISTRIBUTION FOR THE YEARS 2025 TO 2027; (3) APPOINTMENT OF DIRECTORS; AND (4) PR
Earnings Release Classification · 1% confidence The document is a Hong Kong Exchange announcement titled “Annual Results Announcement for the year ended December 31, 2025” and contains audited consolidated financial statements, financial highlights, and an extensive business review and outlook. It is the initial public release of full‐year results (typical of an Earnings Release) rather than the full statutory Annual Report (10-K). Therefore, it best fits the Earnings Release category. FY 2025
2026-03-30 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.